Progyny, Inc. - Common Stock (PGNY)
Healthcare › Services-Misc Health & Allied Services, NEC
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- Trading 68% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 11.3% — below-average profitability
- Revenue growing at 10% annually
Progyny, Inc. - Common Stock (PGNY) is a Healthcare company operating in Services-Misc Health & Allied Services, NEC, listed on the NASDAQ , with a market capitalisation of $1.4 billion . Key value metrics: P/E ratio 23.6, P/B ratio 2.68, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Progyny, Inc. - Common Stock — Fundamental Analysis Summary
Progyny, Inc. - Common Stock (PGNY) is currently trading 68% above its Graham Number of $10.06, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 23.6x.
On financial health, PGNY shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 11.3% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.44.
StockPik's composite Value Score for PGNY is 69/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PGNY reports a moderate gross margin of 23.6% (sector average: 33.5%) and a modest operating margin of 6.6%.
PGNY shows revenue growing at 10% year-over-year, with earnings growing at 8%.